CTIBiotech

cti_logo_tagline
CTIBIOTECH aims to maximize the potential of tissues created by stem cell technologies and biopsies from cancer and skin for human therapeutic benefit

Profile Description

More than 25 years experience

CTIBIOTECH was founded in 2009 by Professor Colin McGuckin and Dr Nico Forraz, pioneers in the fields of regenerative medicine and cancer and creators of the world’s first artificial liver-like tissue using a unique form of embryonic-like adult stem cells. The core expertise of CTIBIOTECH is in cell manipulation, drug testing, biobanking and preclinical trials development. Cells as diverse as blood, immune, liver, pancreas, bone, cartilage, neural and skin-related are made in our laboratories.
Diverse technology platforms

CTIBIOTECH is a fully licensed human tissue biobank and is developing proprietary in-house technologies using cancer and stem cells, but also has developmental partners in:
Medical device development using human cells
In vitro toxicology, drug testing and development
Cosmetics and skin-drug testing and creation of skin models
Provision of cell models for infectious diseases and cancer testing
International profile and partners

CTIBIOTECH has already contributed to FDA registered and CE marked products available now through our partners. International projects in Europe, Asia and the United States have a proven success record.

We offer: R&D, drug testing, medical device co-development and testing, bioassay co-conception and open lab. We provide fully functioning 3D tissue models and specific cell models from patients which improves efficacy given their proximity to human physiology.

For: Pharmaceutical industry (cancer research, regenerative medicine, medical devices), public and private research institutions, contract research organisations.

Key product innovations:

• World’s first mini liver as part of a NASA research programme
• World’s first nervous tissue model
• Stem cell applications
• 3D microtumours

Efficient cosmetics and skin care products require innovation and claim substantiation.

Human skin models provide the means to test new product ideas with scientific credibility.

We offer: In house tests, off the shelf models, co-development/innovation. Open lab using complex skin models from any age range and typology. Skin biopsies and in-house research.

For: Cosmetic and dermatology industries

Key product innovations:

• Ex vivo baby skin models
• In vitro hair models
• Sebaceous gland models
• Pigmentation models
• Scar and stretch marks models
• Sensitive skin models

Top quality human cells, tissues and biological samples that provide the basis for research and innovation.

• National biobank for cancer
• International biobank for clients and partners

We offer: Human biological sample procurement & cell harvesting. Over 50 000 tissue samples in stock or on demand from bio-sourcing via a network of 200 healthcare partners worldwide

Specifically this includes:

• Human skin cells (dermal, epidermal, melanocytes, sebocytes …)
• Oral and facial cells and tissues
• Subcutaneous tissues and organs
• Blood and bone marrow
• Cancer and associated cells
• Pathological tissues
• Cell purification and characterisation (CD34, 56, T, B)

Key product innovations:

• 3D printed tissue models
• Animal product free human cell models

Leave a Comment

Time limit is exhausted. Please reload the CAPTCHA.